Femasys Inc is trading 6.4% down at $3.92 today, appearing to pull back after a sharp 9.1% rebound during the previous trading session.
- No new company-specific filings, FDA decisions, or analyst calls have been reported to explain the downward move.
- Given the lack of fresh fundamental news, the decline likely reflects a correction following recent volatility and prior gains.